RESUMEN
Les noves tecnologies han capacitat als serveis de medicina intensiva per poder obtenir I gestionar grans quantitats d'informació que venen de diverses fonts. Aquesta informació s'obté amb diferents dispositius que conformen les TIC (tecnologia de la informació I la comunicació). Les grans bases de dades o Big Data contribueixen a millorar el coneixement I per tant a elaborar millors estratègies de tractament. Amb aquestes possibilitats apareixen un seguit de reptes que ens haurem de plantejar com poden ser: la manera d'obtenir les dades, com canvia la relació del personal sanitari amb el pacient, quin nivell de fiabilitat tenen les dades, com es protegeixen, qui n'és el propietari I com es comparteixen, etc
Las nuevas tecnologías han permitido a los servicios de medicina intensiva poder obtener y gestionar grandes cantidades de información que vienen de varias fuentes. Esta información se obtiene con diferentes dispositivos que conforman las TIC (tecnología de la información y la comunicación). Las grandes bases de datos o Big Data contribuyen a mejorar el conocimiento y por tanto a elaborar mejores estrategias de tratamiento. Con estas posibilidades aparecen una serie de retos que nos tendremos que plantear, como pueden ser: la manera de obtener los datos, como cambia la relación del personal sanitario con el paciente, qué nivel de fiabilidad tienen los datos, como se protegen, quién es el propietario y como se comparten, etc
The new technologies have made the intensive medical services to be able to obtain and manage large amount of data from different sources. This information is obtained by different devices that make up ICT (information and communication technology). The Big Data contribute to improving knowledge and therefore developing better treatment strategies. With these possibilities, there are a number of challenges that we should consider: how to obtain data, how to change the relationship between healthcare staff and the patient, what leve lof reliability they have, how to protect them, who is the owner and how they are shared
Asunto(s)
Humanos , Tecnología de la Información/ética , Unidades de Cuidados Intensivos/ética , Macrodatos , Tecnología de la Información/legislación & jurisprudencia , Cuidados Críticos/ética , Cuidados Críticos/estadística & datos numéricos , Unidades de Cuidados Intensivos/estadística & datos numéricosRESUMEN
BACKGROUND AND AIM: Monitoring of complications in patients undergoing cardiac surgery may be difficult because cardiopulmonary bypass (CPB) can lead to a systemic inflammatory response syndrome because of exposure of blood to nonphysiological surfaces. The purpose of the study was to establish the baseline levels of procalcitonin (PCT) after cardiac surgery in our population in order to analyze a possible induction of the inflammatory response that might interfere with the diagnosis of infection by PCT. METHODS: Serum samples from patients undergoing coronary artery bypass grafting or valve replacement were collected at the time of admission to intensive care unit, after surgery as well as in the first and second postoperative days. Patients were followed for the development of postoperative complications. PCT levels were measured by immunoluminometric assay. RESULTS: The mean PCT values were significantly higher in the first postoperative day in all the groups except the control group. No increased PCT levels were found related neither to duration of CPB, nor to time of aortic clamping. Only patients who presented complications had significantly increased PCT values immediately after surgery (p = 0.004), in the first postoperative day (p < 0.0001), and in the second postoperative day (p < 0.0001) with respect to those who recovered uneventfully. CONCLUSIONS: A slight and transient increase in PCT levels was observed in the first postoperative day after cardiac surgery. Significant elevation of PCT was only observed when complications were present.